NEW YORK, Jan. 17, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, PC, a nationally recognized shareholder rights law firm, reminds investors that class action lawsuits have been filed on behalf of shareholders of Instadose Pharma Corp. (OTCMKTS: INSD), Bright Health Group, Inc. (NYSE: BHG) and First Solar, Inc. (NASDAQ: FSLR). Shareholders have until the deadlines below to ask the court to serve as lead plaintiff. Additional information on each case can be found at the link provided.

Instadose Pharma Corp. (OTCMKTS:INSD)

Course period: December 8, 2020 – November 24, 2021

Lead Applicant Deadline: February 28, 2022

On November 23, 2021, the United States Securities and Exchange Commission (“SEC”) announced a temporary suspension of trading in Instadose securities due to concerns regarding the adequacy and accuracy of company information on the market. The SEC specifically noted increases in Instadose’s stock price and stock volume not supported by the company’s assets and financial information, the transactions may be associated with persons related to a control person of the company and operations of the company’s Canadian subsidiary. On this news, the Company’s stock price declined $3.69 per share, or approximately 13%, from $28.30 per share to close at $24.61 per share on November 23, 2021, either just before the break in negotiations.

On December 9, 2021, when the Company’s securities resumed trading, the stock price opened and closed at $2.00 per share.

For more information on the Instadose class action, please visit:

Bright Health Group, Inc. (NYSE: BHG)

Class Period: June 24, 2021 IPO; June 24, 2021 – November 10, 2021

Lead Applicant Deadline: March 7, 2022

In June 2021, Bright Health completed its initial public offering (“IPO”), selling approximately 51 million shares of common stock for $18.00 per share.

On November 11, 2021, Bright Health released its third quarter financial results, reporting earnings per share (“EPS”) of -$0.48 as calculated under U.S. Generally Accepted Accounting Principles (“GAAP”) , missing consensus estimates of $0.31. The company also reported a sharp increase in the company’s medical expense ratio (“MCR”), advising investors that its MCR “for the third quarter of 2021 was 103.0%, including an adverse impact of 540 basis points. cost base related to COVID-19 and an Adverse Impact of 900 basis points primarily due to a cumulative reduction in premium income due to an inability to capture the risk adjustment on newly added lives.

On this news, Bright Health’s stock fell $2.36, or 32%, to close at $4.94 per share on Nov. 11, 2021, hurting investors.

For more information on the Bright Health class action lawsuit, please visit:

First Solar, Inc. (NASDAQ: FSLR)

Course period: February 22, 2019 – February 20, 2020

Lead Applicant Deadline: March 8, 2022

On January 15, 2020, Barclays reported that First Solar had “apparently been, largely, priced out of the U.S. downstream solar market” and that the company had concealed its rapidly declining market share through misleading financial reports by including projects in its Project Development Pipeline that had actually been completed in previous years.

On this news, First Solar’s stock fell $4.03, or 7%, to close at $54.75 per share on January 15, 2020, hurting investors.

Then, on February 6, 2020, Barclays said that, in an attempt to regain market share, First Solar was “bidding more aggressively, driving down [Project Development contract] price, and finally reduce margins.

On this news, First Solar’s stock fell $0.45 to close at $52.65 per share on Feb. 6, 2020, further hurting investors.

Then, on February 20, 2020, First Solar announced that it was considering selling its project development business. The company also revealed that it was experiencing “challenges with certain aspects of the overall cost per watt” and that it would not meet its cost per watt targets.

On this news, First Solar’s stock fell $8.73, or 15%, to close at $50.59 per share on Feb. 21, 2020, further hurting investors.

For more information on the First Solar class action, please visit:

About Bragar Eagel & Squire, PC:

Bragar Eagel & Squire, PC is a nationally recognized law firm with offices in New York, California and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivatives and other complex litigation before state and federal courts across the country. For more information about the company, please visit Lawyer advertisement. Prior results do not guarantee similar results.

Contact details:

Bragar Eagel & Squire, CP
Brandon Walker, Esq.
Alexandra B. Raymond, Esq.
(212) 355-4648
[email protected]